Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Human Genome investors stand to gain 13% on GlaxoSmithKline, Bloomberg reports
Human Genome investors stand to gain 13% on GlaxoSmithKline, Bloomberg reports
Human Genome investors stand to gain 13% on GlaxoSmithKline, Bloomberg reports
Submitted by
admin
on June 12, 2012 - 10:52am
Source:
Yahoo/Fly on the Wall
News Tags:
Human Genome Sciences
GSK
M&A
Headline:
Human Genome investors stand to gain 13% on GlaxoSmithKline, Bloomberg reports
Do Not Allow Advertisers to Use My Personal information
